Targeting PCSK9 inhibition to patients: Highest risk – highest benefit
Report: PCSK9 Forum Editor Professor Derick Raal (University of Witwatersrand, Johannesburg, South Africa) comments on this recent proposal.
Read the report
Video: Is number needed to treat a practical approach to rationalising PCSK9 inhibitor therapy?
Watch the video
Paediatric FH: what do we still need to know?
Royal Perth Hospital Unit, School of Medicine, University of Western Australia, Australia
With more than 2 years since the European Atherosclerosis Society (EAS) released a Consensus Statement about paediatric familial hypercholesterolaemia (FH, inherited high cholesterol), questions on optimal care remain.
Read the article